Stage IV Renal Cell Carcinoma
2 clinical trials · Condition
◉ Watch Stage IV Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer (NCT04670445) | Massachusetts General Hospital | 2021-01-23 |
| IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC) (NCT00351949) | Immutep S.A.S. | 2005-09-01 |
Track Stage IV Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.